FDA product code OPT: Infrared Hematoma Detector

OPT is the FDA product code for infrared hematoma detector. It is a Class II device, regulated under 21 CFR 882.1935 and reviewed by the Neurology panel. FDA has cleared 4 510(k) submissions under OPT, 2 in the last five years. The average 510(k) review took 230 days (median 235); 211 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 1 recall for OPT devices.

Definition

To employ near-infrared spectroscopy that is intended to be used to evaluate suspected brain hematomas.

Classification

FieldValue
Device nameInfrared Hematoma Detector
Device classClass II
Regulation21 CFR 882.1935
Review panelNE — Neurology
Medical specialtyOphthalmic
Premarket route510(k)

510(k) clearances per year for OPT

YearClearancesAvg. review days
20201164
20221259
20241211

Top OPT applicants

ApplicantClearancesLatest
Infrascan, Inc.42024-12-12

Most recent OPT clearances

510(k)ApplicantDeviceDecision dateReview days
K241389Infrascan, Inc.Infrascanner Model 2500 (Model 2500)2024-12-12211
K211617Infrascan, Inc.Infrascanner2022-02-09259
K200203Infrascan, Inc.Infrascanner2020-07-10164
K120949Infrascan, Inc.INFRASCANNER2013-01-11287

Recalls for OPT devices

1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2013-10-16.

Frequently asked questions

What is FDA product code OPT?

OPT is the FDA product code for infrared hematoma detector. It is a Class II device, regulated under 21 CFR 882.1935 and reviewed by the Neurology panel.

What device class is OPT?

Class II, regulation 21 CFR 882.1935. Typical premarket route: 510(k).

How long does a 510(k) take for product code OPT?

Across 4 cleared submissions the average was 230 days from receipt to decision (median 235).

Which companies have the most OPT clearances?

Infrascan, Inc. (4).

Have OPT devices been recalled?

Yes: 1 product recalls across 1 recall events; the most recent began 2013-10-16.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Neurology product codes · FDA product code lookup